Blood Journals Portfolio
Portfolio of peer-reviewed journals from ASH including Blood, Blood Advances, Blood Global Hematology, Blood ICT, Blood Neoplasia, Blood RCI, and Blood VTH linktr.ee/bloodjournalsportfolio
- New issue of Blood out now! Featuring Human missense F3 variants impact blood clotting, Liberating eligibility criteria in AML clinical trials, PIKfyve blockade exposes lysosomal vulnerability in myeloma and more. Explore here: ashpublications.org/blood/issue/...
- 🎙️ Just published a new episode of Blood Podcast: Biologic Insights and Clinical Trial Design for AML. Have a listen:
- AML cells are resistant to proteasome inhibitors because they activate HSF1 and autophagy to prevent proteostasis disruption. Read in Blood: buff.ly/9Ujg9V7
- Loss of CD38 in myeloma cells drives aggressive tumors with bone damage, kidney metastases, and poor survival in mice. Read in Blood Advances: buff.ly/BqvBEig
- Cryo-EM structure reveals a large interface involving the EGF2 and serine protease domains of fXa and the A2 and A3 domains of fVa. Read in Blood: buff.ly/QyI9bm5
- Reposted by Blood Journals Portfolio[Not loaded yet]
- 🎙️ Just published a new episode of Blood Podcast: How I Treat Series on Subsets of Acute Lymphoblastic Leukemia. Have a listen: bloodpodcast.transistor.fm/episodes/how...
- Check out 'Clinical Features of Systemic Amyloidosis: A Scoping Review' in Blood Advances ➡️ ashpublications.org/bloodadvance...
- Reposted by Blood Journals Portfolio[Not loaded yet]
- Huge news for open science! We’re excited to share that two of our journals, Blood Global Hematology and Blood Red Cells & Iron, are now indexed in the Directory of Open Access Journals (DOAJ). This means even greater visibility, accessibility, and impact for the research. @doaj.bsky.social
- This article, recently published in Blood ICT, was accepted through our second look rapid response program. Check it out and consider giving your own research a second chance: ashpublications.org/bloodict/art...
- Mll fusions are found in both adult & childhood leukemia and can be associated with lymphoid & myeloid malignancies. The study found that the MLL-ENL fusion induced the SKADA1 gene more markedly in fetal than adult hematopoietic progenitors. Read more: ashpublications.org/bloodneoplas...
- New issue of Blood Advances out now featuring Cold clues in pediatric autoimmune hemolytic anemia, Macrophages are key mediators of platelet refractoriness, Weighing the evidence on cabozantinib and thrombotic risk and more. Explore here: ashpublications.org/bloodadvance...
- Bispecific antibodies appear to be a promising therapeutic option, offering durable responses compared to chemotherapy and targeted therapy. Read the full article in Blood Advances: buff.ly/19Ev4Ai #MCL #BloodAdvances
- We have a winner of the 10th Annual Blood Cover Art Contest! Thanks to all who voted and kudos to the doctors who authored the article 'Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT.' ashpublications.org/blood/pages/...
- 🎙️ Just published a new episode of Blood Podcast: How I Treat Series on the 25th anniversary of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Have a listen:
- New issue of Blood out now featuring A Padua moment for factor VIII gene therapy, Faulty antibody editing permits antiplatelet B cells in ITP, USP25 and platelet hyperreactivity in aging, and more. Explore here: ashpublications.org/blood/issue/...
- Patients generally reported a higher incidence of common symptoms compared with clinician reports. Pola-R-CHP and R-CHOP similarly improved HRQoL and lymphoma symptoms in previously untreated DLBCL. Read in Blood: buff.ly/ugYu3lY #DLBCL #Blood
- AI reduces manual analysis time for the detection of MRD to 1 minute per case, on average. Read the full study in Blood Advances: buff.ly/NG1Zlty #AI #BloodAdvances
- LAST CHANCE to vote in the 10th Annual Blood Cover Art Contest! Honor all the incredible research published last year and cast your vote here by tomorrow at noon: pr.easypromosapp.com/p/997812 🩸 Pictured is the cover art from Blood Volume 145, Issue 1
- This article, recently published in Blood ICT, was accepted through our second look rapid response program. Check it out and consider giving your own research a second chance: ashpublications.org/bloodict/art...
- New issue of Blood out now featuring A small step yet one giant leap for cGVHD biomarkers, Time to say adieu to FISH in myeloma diagnostics, miR-aculous effects for hemophilic arthropathy, and more. ow.ly/o6pw50XXpwj #BloodJournal #NewIssue
- 🎙️ Just published a new episode of Blood Podcast: How I Treat Series on Hematologic Complications in Pregnancy. Have a listen:
- There's just 1 week left to vote in our 10th Annual Blood Cover Art Contest! Anyone is welcome to vote once and voting will remain open until January 21st. Click here to participate: ow.ly/8Qk750XWI4g 🪼 Pictured is the cover of Blood Volume 146, Issue 16 #CoverArt #Blood
- Increased telomerase complex activity in TP53-mutated AML results in higher TC compared with other myeloid neoplasms with other mutations. Read in Blood: ow.ly/Ijki50XTH6Y #AML #Blood
- New issue of Blood Advances out now featuring MRD assessment by flow cytometry in B-ALL made easier, Targeting the lectin pathway in TA-TMA, AI-generated peptides for research and clinical practice, and more. Explore here: ow.ly/6UUP50XWfXv #BloodAdvances #NewIssue
- Reposted by Blood Journals Portfolio[Not loaded yet]
- Increased telomerase complex activity in TP53-mutated AML results in higher TC compared with other myeloid neoplasms with other mutations. Read in Blood: buff.ly/Hr2z7j1 #AML #Blood
- Explore all of the abstracts from our 67th Annual Meeting and see what's driving the field of hematology forward today: ashpublications.org/blood/issue/... #ASH25 #Abstracts
- Off-the-shelf bispecific CD133-CD19 CAR-iNKT cells eradicate CAR antigen–high and –low medullary and leptomeningeal KMT2Ar ALL. Read in Blood: buff.ly/HIlsUq7 #ALL #BloodJournal
- Notch activity decrease in HSCs induces myeloid-biased stem cell expansion and clustering at the expense of hematopoietic regeneration. Read in Blood: buff.ly/E5NpGPk #Blood
- HSCT yields satisfactory long-term outcomes in patients with PNP deficiency. OS was best in early-diagnosed patients without neurologic symptoms. Read in Blood: buff.ly/MhfvvBD #HSCT #BloodJournal
- Test your knowledge and earn CME credit! If you don’t already have it, now is the perfect time to get our Hematology 2025 ASH Education Program. Digital access is FREE for members and #ASH25 attendees. Anyone can purchase digital and/or print editions here apps.hematology.org/store/produc...
- "Drug development in MZL: caring for the forgotten child" read the full article in Blood: buff.ly/92qvG15 #MZL #BloodJournal
- Reposted by Blood Journals Portfolio[Not loaded yet]
- New issue of #Blood out now featuring Hematopoietic transplantation for PNP deficiency, The telomeric puzzle in TP53-mutant myeloid neoplasms, and more. ashpublications.org/blood/issue/... #BloodJournal #NewIssue
- Reposted by Blood Journals Portfolio[Not loaded yet]
- 🎙️ Just published a new episode of Blood Podcast: Review Series on Marginal Zone Lymphoma . Have a listen:
- Brentuximab vedotin addition du gemcitabine safely increases treatment efficacy in patients with relapsed and refractory PTCL. Read in Blood Advances: buff.ly/mnclkWP #hemesky
- 'Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis' read in Blood Advances: buff.ly/kzxbRAk #bloodadvances
- We're excited to share that Blood Advances has a new Associate Editor, Dr. Steven Lane. He's a clinical hematologist and researcher at Royal Brisbane & Women's Hospital and runs a busy research group at the Queensland Institute of Medical Research. Welcome Dr. Lane! #BloodAdvances
- Last call to apply for our 2026 Editorial Fellowship! 📑 This is an incredible opportunity for either late-stage fellows or early-career faculty members interested in medical publishing to be mentored by a Blood Journals' Editor for 9 months. Apply: ashpublications.org/editorialfellowship
- In honor of Blood's 80th Anniversary, Editor in Chief Dr. Andrew Roberts reflects on eight decades of hematology research and looks to the future of the journal. Read Dr. Roberts' editorial here: ashpublications.org/blood/articl...
- Today marks the 80th anniversary of Blood Journal. We're looking forward to commemorating this milestone throughout 2026 and hope you enjoy the new issue out now. ashpublications.org/blood/issue/... Happy new year! #Anniversary #BloodJournal
- 🎙️ Just published a new episode of Blood Podcast: VTE Recurrence Risk Factors and poor-response AML Transplant Outcome Indicators. Have a listen:
- We're excited to welcome a new editor to the Blood Advances editorial team! Dr. O'Brien is a pediatric hematologist at Nationwide Children's Hospital & Professor of Pediatrics at Ohio State University College of Medicine. Her new role will start tomorrow, please join us in congratulating Dr. O'Brien
- Our new growth curves, based on a Kenyan cohort with SCA, will provide useful disease-specific references for clinicians and researchers. Read in Blood Global Hematology: buff.ly/0glduVU
- In older and/or frail patients with CLL, treatment with acalabrutinib is highly efficacious and can improve underlying frailty. Read full article in Blood: buff.ly/XmaHzl0
- New issue of Blood out now featuring: Acalabrutinib to assail CLL in the frail, Matchmaking gene therapy with mimetic antibodies, Beyond Arg39: new insights into antiphospholipid antibodies, and more. ashpublications.org/blood/issue/...
- 🎙️ Just published a new episode of Blood Podcast: Novel Treatment Targets for Hemophilia A and AML. Have a listen:
- MECOM promotes malignant stem cell–like states in aggressive AMLs by directly repressing prodifferentiation gene regulatory programs. Read the plenary paper in Blood: buff.ly/MUfiZMN #BloodJournal #PlenaryPaper #AML
- PM PET showed prognostic impact in daratumumab-treated patients. Better PFS was shown for patients who were both PET- and MFC-negative. Read in Blood: buff.ly/84vltb5
- Our 67th Annual Meeting may be over, but the abstracts live on. Explore the more than 8,200 #ASH25 abstracts here: www.hematology.org/meetings/ann...
- The 2025 Blood Cover Art Contest is live! In recognition of the authors who published their research this year, and the images used for the advancement of hematology, we are asking art enthusiasts to vote for their favorite 2025 blood cover here: pr.easypromosapp.com/p/997812
